North America Analysis
Home 2023

Archives

Development of a new gene therapy drug as a treatment for hypophosphatasia

The current primary treatment for hypophosphatasia is enzyme replacement therapy; however the development of a new gene therapy drug, ARU-2801, may change the landscape forever.

Follow Open Access Government